Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00176774
Status:
COMPLETED
Last Update Posted:
2012-02-07
First Post:
2005-09-12
Brief Title:
Irinotecan 5-Fluorouracil and Leucovorin in Colorectal Carcinoma
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Study Overview
Official Title:
A Pilot Trial of Irinotecan 5-Fluorouracil and Leucovorin Combined With the Anti-Angiogenesis Agent Tetrathiomolybdate in Metastatic Colorectal Carcinoma UMCC 0075
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will examine an investigational experimental agent Tetrathiomolybdate TM combined with the chemotherapy drugs Irinotecan 5-Fluorouracil 5-FU and Leucovorin LV This study will evaluate the safety and tolerability of the combination of these drugs when they are used in the treatment of metastatic colorectal cancer
This is a pilot clinical trial which will be studying the reactions of the patients body and tumor to the experimental treatment described above The purpose of this study is to find out what kind of side effects this experimental treatment causes and see how often these side effects occur
This is a pilot clinical trial which will be studying the reactions of the patients body and tumor to the experimental treatment described above The purpose of this study is to find out what kind of side effects this experimental treatment causes and see how often these side effects occur
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None